Entera Bio
ENTX
12 hedge funds and large institutions have $1.87M invested in Entera Bio in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 3 closing their positions.
0.03% more ownership
Funds ownership: 8.92% → 8.95% (+0.03%)
0% more funds holding
Funds holding: 12 → 12 (0)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
14% less capital invested
Capital invested by funds: $2.17M → $1.87M (-$296K)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$11.3K |
| 2 |
Millennium Management
New York
|
+$8.38K |
| 3 |
Renaissance Technologies
New York
|
+$5.38K |
| 4 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
+$2.21K |
| 5 |
Group One Trading
Chicago,
Illinois
|
+$254 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
-$22K |
| 2 |
Osaic Holdings
Scottsdale,
Arizona
|
-$633 |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$331 |
| 4 |
Morgan Stanley
New York
|
-$74 |
| 5 |
Simplex Trading
Chicago,
Illinois
|
-$10 |
ENTX Hedge Fund Activity: Q3 2023 in Review
12 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in Entera Bio (ENTX) for Q3 2023, worth a combined $1.87M — down 14% from $2.17M a quarter earlier.
Fund positioning in ENTX was balanced in Q3 2023: 3 funds opened new positions, 3 closed out, 3 added to existing stakes and 3 trimmed.
The largest buyer was Citadel Advisors, adding an estimated $11.3K. The largest seller was HRT Financial, exiting entirely with an estimated $22K sold.
- 12 institutional investors held Entera Bio (ENTX) as of Q3 2023, unchanged from Q2 2023.
- Funds reported $1.87M of Entera Bio stock for Q3 2023, down 14% quarter-over-quarter.
- 3 funds opened new Entera Bio positions in Q3 2023 and 3 closed out, a net change of 0 holders.
- The largest Entera Bio buyer in Q3 2023 was Citadel Advisors, an estimated $11.3K added.
- The largest Entera Bio seller in Q3 2023 was HRT Financial, an estimated $22K sold.
Based on aggregated 13F filings for Q3 2023.